Indivior to Raise $400 Million via Convertible Notes, Repurchase Shares
Event summary
- Indivior plans to issue $400 million in convertible senior notes due 2031, with a potential additional $60 million option.
- The company intends to use $239 million of proceeds to repay existing debt and $75 million to repurchase shares.
- The notes will be offered to qualified institutional buyers under Rule 144A.
- Noteholders have the right to convert notes and may require repurchase under certain conditions, including a 130% threshold of Indivior's common stock price.
The big picture
Indivior's move to issue convertible notes and repurchase shares is a common strategy for companies seeking to optimize their capital structure and manage shareholder dilution. The use of Rule 144A indicates a targeted offering to institutional investors, suggesting a desire to avoid broader market scrutiny. This financing comes as the company navigates a complex regulatory landscape and faces ongoing scrutiny related to opioid treatments.
What we're watching
- Conversion Dynamics
- The success of this offering hinges on Indivior’s stock price performance; sustained trading above 130% of the conversion price will trigger mandatory redemption, potentially diluting existing shareholders.
- Debt Management
- The repayment of the term loan and revolving credit facility suggests a desire to simplify Indivior’s capital structure, but the introduction of convertible notes adds complexity and potential dilution.
- Shareholder Alignment
- The concurrent share repurchase, priced near the market rate, aims to support the stock price and potentially lower the effective conversion price, but may be perceived as a short-term fix for underlying valuation concerns.
Related topics